genOway Shanghai - Legal letter - Product name change

Intellectual property

Event
-
June 27, 2025

In an effort to align our global catalog, our product naming strategy will now be consistent across both our Chinese and French teams' communication and documentation.

Access legal letter here

genOway Shanghai - Legal letter - Product name change

Get in touch

Let us know how we can help

Other news & events

14th Tumour Models Summit London 2025, December 3-4, 2025
Conference
genOway presentation
Event
-
Dec 2025
Read on
genOway Shanghai at the 16th China International Pharmaceutical Expo 2025
Conference
Event
-
Nov 2025
Read on
7th Myeloid-Directed Summit 2025, November 18-20, 2025
Conference
genOway presentation
Event
-
Nov 2025
Read on
genOway Shanghai at BIONNOVA Beijing Forum 2025
Conference
Event
-
Sep 2025
Read on
genOway Shanghai at 2025 Future Cell Therapy Executives Summit
Conference
Event
-
Sep 2025
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe